BETonMACE Cognitive Assessment Results Webcast and Conference Call

As previously reported, the prespecified cognition assessment results of BETonMACE were presented on December 5th during the Clinical Trials on Alzheimer's Disease (CtAD) Congress 2019; additional details can be found HERE. Following the CtAD presentation, the Company held a conference call and webcast on December 6th, 2019; the presentation slides can be downloaded HERE.